Story perspectives

Inato Raises $20M to Revolutionize AI in Clinical Trials

1/29/2025

23 2

Summary

Story summary

Inato has secured $20 million in Series A2 funding to supercharge its AI technology for clinical trials, slashing patient prescreening times by more than half. Simultaneously, M42 in Abu Dhabi is harnessing AI to tackle healthcare delivery challenges, aiming to bridge gaps caused by workforce shortages and health disparities with groundbreaking solutions.

History

Historical Context

Inato's $20 million funding for AI in clinical trials reflects a broader trend in healthcare innovation. Since the 2000s, technology has increasingly transformed clinical research, improving efficiency and patient recruitment. Similarly, Abu Dhabi's M42 initiative addresses healthcare disparities, echoing past efforts like the UAE's 2011 Jawda initiative, which aimed to enhance healthcare quality through systematic reforms and performance monitoring.

1 of 2

Story summary

Inato has secured $20 million in Series A2 funding to supercharge its AI technology for clinical trials, slashing patient prescreening times by more than half. Simultaneously, M42 in Abu Dhabi is harnessing AI to tackle healthcare delivery challenges, aiming to bridge gaps caused by workforce shortages and health disparities with groundbreaking solutions.

1 / 2